Company Filing History:
Years Active: 2023-2024
Title: Chisato Nagai: Innovator in Pemafibrate Therapy
Introduction
Chisato Nagai is a prominent inventor based in Chuo-ku, Japan. She has made significant contributions to the field of medicine, particularly in the development of dosing regimens for pemafibrate therapy. With a total of three patents to her name, her work focuses on improving patient safety and treatment efficacy.
Latest Patents
Nagai's latest patents revolve around the formulation of a medicament for safely treating patients in need of pemafibrate therapy. The patents detail methods to avoid or suspend the concomitant use of pemafibrate with certain medications, specifically those containing an OATP1B inhibitor. This approach aims to suppress an increase in plasma concentration of pemafibrate, thereby enhancing the safety of the treatment.
Career Highlights
Chisato Nagai is currently employed at Kowa Company Limited, where she continues to innovate in the pharmaceutical sector. Her work is characterized by a commitment to patient safety and effective treatment strategies.
Collaborations
Nagai collaborates with notable colleagues, including Ryu Oshima and Masatoshi Ito, to advance her research and development efforts.
Conclusion
Chisato Nagai's contributions to pemafibrate therapy exemplify her dedication to improving medical treatments. Her innovative approach and collaborative spirit continue to make a positive impact in the field of medicine.